reported a case of a patient with MM who developed motor dysfunction after receiving BCMA CAR‐T therapy, with single‐cell data confirming BCMA expression in the caudate nucleus, suggesting potential neurotoxicity.[141] Additionally, MacKay M et al. Here, TNFRSF17 is linked to Miyoshi myopathy.